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Paal Skytt Andersen3 and Christian Torp-Pedersen1
Abstract
Background: Staphylococcus aureus bacteremia (SAB) is the leading cause of infective endocarditis in several
countries. Since socioeconomic status (SES) is known to influence the risk of infectious diseases in general, we
aimed to investigate the association between SES and SAB, and risk of subsequent endocarditis in a nationwide
adult population.
Methods: All Danish residents were consecutively included at age ≥ 30 years during 1996–2010. We obtained
information on SES (highest attained educational level), comorbidities, and microbiologically verified SAB by
cross-linking nationwide registries. The incidence rate ratios (IRRs) of SAB and later endocarditis were investigated using
Poisson regression models adjusted for sex, age and year (reference = highest SES).
Results: Our study population comprised 3,394,936 individuals (median age = 43.2 years). Over a median follow-up of
15.9 years, 13,181 individuals acquired SAB. SES was inversely associated with SAB acquisition, which declined with
increasing age, e.g. in individuals with lowest SES, IRRs were 3.78 (95% confidence interval [CI] = 2.89–4.95) in age 30–
50 years, 1.87 (CI = 1.60–2.18) in age > 50–70 years and 1.31 (CI = 1.11–1.54) in age > 70 years (interaction-p < 0.0001).
Adjustment for comorbidities attenuated the IRRs, but the pattern persisted. No
association between SES and endocarditis risk among patients with SAB was observed.
Conclusions: Decreasing SES was associated with an increased risk of SAB, particularly in younger adults. SES was not
associated with risk of subsequent endocarditis.
Keywords: Staphylococcus aureus, Social status, Young adults, Endocarditis, Risk factors, Education
Background
Staphylococcus aureus bacteremia (SAB) is among the top
ten causes of death in the Western world [1–3], and the
high occurrence of multi-resistant Staphylococcus aureus
limits the therapeutic options in many countries [4, 5].
While a number of risk factors for acquiring SAB have
been explored [6–10], large-scale studies on the impact of
socioeconomic status (SES) on risk of SAB is sparse.
Furthermore, infective endocarditis is a frequent and
severe complication to SAB [11], however it is as yet un-
explored whether SES is associated with an increased risk
of subsequent endocarditis in patients with SAB.
Studies have suggested a link between low SES and
increased risk of infectious diseases in general [12–14]
as well as increased all-cause mortality following
bacteremia [15]. However, only one study (case-control)
has examined the association between SES and risk of
community-acquired bacteremia, with risk of SAB studied
as a sub-analysis. In this study, the associated risk of SAB
in individuals with low educational level was 4-fold
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increased compared with individuals with a high educa-
tional level [16].
Identification of individuals at high risk of SAB is crucial
to improve prophylactic and treatment strategies. We
therefore conducted a nationwide cohort study to assess
the association between highest attained educational level
and risk of acquiring primary SAB, and risk of subsequent
endocarditis in an adult Danish population.
Methods
Data sources and definitions
To identify all Danish residents who were ≥30 years old
during 1996–2010 nationwide registries were cross-linked
at an individual level using the personal identification
number assigned to all Danish residents at birth or immi-
gration [17]. From the Danish Civil Registration System
we identified all Danish residents who were ≥30 years old
during 1996–2010, and further obtained information on
vital statistics (date of birth/death and sex) and demo-
graphic data (immigration/emigration status).
Exposure, socioeconomic status (SES)
Since the majority of the Danish population would be
fairly young at study inclusion and since educational
level is known to reflect an individual’s future income
[18], we defined SES as highest attained educational
level at study entry categorized as follows: 1) basic
school (primary, lower secondary); 2) upper secondary
(general secondary, technical secondary; “high-school”);
3) vocational (e.g. electrician or chef ); 4) short or
medium length higher education (Academy Profession
Degree, Professional Bachelor’s Degree, University
Bachelor’s Degree; 2–4 years following upper second-
ary); 5) Master’s Degree or Ph.D.; as described else-
where [19]. Data were achieved from the Population’s
Education Registry, which contains information on each
individual’s highest attained education for 96.4% of the
Danish population between 15 and 69 years of age [20].
We excluded individuals with missing data on educa-
tional level, including all first generation immigrants.
For an additional analysis, we further obtained infor-
mation about annual income in the year prior to study
inclusion from the Income Statistics registry on personal
income (e.g. income in year 2000 if included in 2001),
which was categorized into quartiles using the highest
quartile as reference [21].
Outcomes
The primary outcome was risk of microbiologically veri-
fied SAB, which was identified in the National Danish
Staphylococcus aureus Bacteremia Database from the na-
tional reference laboratory at Statens Serum Institut. This
registry was established as a collaboration between the
Danish departments of Clinical Microbiology and Statens
Serum Institut [22] in 1957. Isolates positive for
Staphylococcus aureus are sent to Statens Serum Insti-
tut (on a voluntary level), which curates the National
Danish Staphylococcus aureus Bacteremia Database.
The registry comprises isolates and clinical data from
>90% of all positive blood cultures in Denmark.
The secondary outcome was subsequent endocarditis in
individuals diagnosed with SAB. We defined endocarditis
following SAB as a diagnosis of endocarditis within 3
months after admission for SAB. All individuals with a
diagnosis of endocarditis prior to SAB were excluded. The
date of endocarditis was defined as the day of discharge.
This information was obtained from the Danish National
Patient Registry (ICD-10 codes = I33, I38) that holds dates
and discharge diagnoses for all public and private hospital
admissions in Denmark since 1977.
Comorbidities, prosthetic devices and surgical procedures
Information on medical conditions (e.g. diabetes, hyper-
tension, cancer and valvular heart disease), prosthetic
device implantations (e.g. pacemaker and hip prosthesis)
and whether individuals had received chronic dialysis
treatment or had surgery within 6 months prior to study
inclusion were obtained from the Danish National Patient
Registry [23]. Cancer at baseline was defined as any cancer
diagnosis within 5 years prior to inclusion. Since diabetes
and hypertension are primarily treated at the general
practitioner, and thus not necessarily registered in the
Danish National Patient Registry [24], we obtained infor-
mation on these specific conditions by use of claimed
prescriptions as recorded in the National Prescription
Registry since 1995. All prescribed drugs are registered by
the Anatomical Therapeutic Classification (ATC) with
information on amount dispended and date of dispensing,
and has been shown to be accurate [25]. Diabetes was de-
fined as first claimed prescription for a glucose-lowering
drug (ATC code = A10). We defined hypertension as
claimed prescriptions for two different classes of antihy-
pertensive drugs, as described in details previously [26].
Statistical analyses
All Danish residents were consecutively included between
January 1, 1996 and December 31, 2010, thus ensuring a
follow-up period of minimum 1 year. Each individual was
included in the study population at the last of the follow-
ing events: January 1, 1996; the date the individual turned
30 years old; or the date of immigration to Denmark.
The population was followed until primary admission
for SAB, emigration, death, or December 31, 2011,
whichever came first.
Baseline characteristics were defined as comorbidities
prior to study inclusion and presented as median with
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interquartile range (IQR) for continuous variables, and
as frequencies with percentages for categorical variables.
Multivariable Poisson regression models were used to
assess the associations between SES and the risk of SAB.
The Lexis macro was used for all analyses and included
two time-scales: calendar time and age split in 1-year time
bands after January 1, 1996. The expected numbers of
events were calculated according to time at risk within
each time band.
In our primary model we adjusted for age, sex and
calendar year, and in a secondary model we addition-
ally adjusted for the aforementioned comorbidities.
Comorbidity status was updated time-dependently.
For surgery during follow-up we introduced a “post
surgery time period” where individuals were consid-
ered exposed to surgery from date of operation and 3
months onwards. Moreover, we examined whether the
association between SES and risk of SAB differed by
age or sex by use of statistical interaction tests, and
stratified as appropriate.
Lastly, we explored the association between SES and
risk of subsequent endocarditis in an analysis only includ-
ing patients with SAB, and adjusted for age, sex and calen-
dar year.
Results were reported with 95% confidence limits.
Model assumptions (constant rate ratios for each inter-
val) were tested by performing the same analyses using
smaller time intervals (6 month intervals) and found
valid unless otherwise indicated. Statistical calculations
were performed using SAS for Windows, version 9.4
(SAS Institute Inc., Cary, NC).
Additional and sensitivity analyses
Given the known close correlation between SES and co-
morbidities, we explored cumulative time exposed to se-
lected comorbidities prone to increase the risk of SAB
and endocarditis according to level of SES.
In an additional analysis we defined SES according to
annual household income in the year prior to study in-
clusion, and explored the association between SES and
risk of SAB adjusted for age, sex and calendar year.
Hypothetically, a lack of association between SES and
risk of subsequent endocarditis in patients with SAB
could appear due to a disproportional higher mortality
among bacteremic patients from the lowest SES. Con-
sequently, we examined cumulative incidences of sub-
sequent endocarditis according to SES with death as
competing risk. Finally, we examined potential differ-
ences in the association between SES and infective
endocarditis in patients with SAB prior to and after
2007, since the Danish guidelines have recommended
doctors to perform echocardiography in patients with
SAB from this year [27].
Ethics approval and consent to participate
This project was approved by the Danish Data Protec-
tion Agency with reference number 2007–58-015/
GEH-2014-018 I-Suite number: 02736. The clinical
Danish Staphylococcus aureus Database was approved
by The Danish Health and Medicines Authority (reference
number 2007–54-0295). In Denmark, no ethics approval
or informed consent is needed for retrospective register
studies. All data are held by Statistics Denmark, which
also has the administrative rights to the data and encrypts
the identification number likewise in all datasets.
Results
The study cohort comprised 3,394,936 individuals (Fig. 1)
with a median age of 43.2 years (IQR = [30.0;56.0]). The
distribution of men and women were overall equal (50.7%
male), but across levels of SES, more men had vocational
education and long higher education as highest attained
education (Table 1). Individuals with the lowest SES were
in general older, and rheumatic diseases, cancer, chronic
obstructive pulmonary disorder and acute myocardial in-
farction were observed more frequently (Table 1).
During amedian follow-up of 15.9 years (IQR = [10.7;16.0])
we identified 13,181 persons with a first hospitalization
for SAB (62.9% male). We observed low SES to be asso-
ciated with a nearly two-fold increased risk of SAB
compared with the highest SES adjusted for age, calen-
dar year and sex (Fig. 2). The association between SES
and risk of SAB differed by age (p for interaction
<0.0001), and we therefore stratified our results by age
Fig. 1 Flowchart. Flowchart illustrating the selection of the study
cohort through nationwide registries
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Table 1 Baseline characteristics of the cohort stratified by socioeconomic status
Highest attained education Basic school Upper secondary Vocational Short/medium length higher education Master’s Degree/Ph.D.
N (%) 1,230,283 (36.2) 161,342 (4.8) 1,291,659 (38.1) 553,451 (16.3) 158,201 (4.7)
Age (IQR) 50.9 (36.5–70.5) 30.0 (30.0–37.3) 41.4 (30.0–52.7) 38.9 (30.0–49.9) 38.3 (30.0–49.8)
Male (%) 543,959 (44.2) 80,772 (50.1) 732,954 (56.8) 236,722 (42.8) 100,711 (63.7)
Diabetes (%) 2384 (0.2) 212 (0.1) 1848 (0.1) 944 (0.2) 222 (0.1)
Hypertension (%) 843 (0.1) 255 (0.03) 1337 (0.2) 555 (0.1) 106 (0.1)
Periphere vascular disease (%) 8686 (0.7) 173 (0.1) 4840 (0.4) 1069 (0.2) 233 (0.2)
Acute myocardial infarction (%) 29,126 (2.4) 476 (0.3) 17,577 (1.4) 3862 (0.7) 1232 (0.8)
Valvular heart disease (%) 1754 (0.1) 83 (0.1) 1126 (0.1) 337 (0.1) 124 (0.1)
Chronic heart failure (%) 6555 (0.5) 153 (0.1) 3346 (0.3) 830 (0.2) 288 (0.2)
Mild liver disease (%) 6999 (0.6) 437 (0.3) 5411 (0.4) 1438 (0.3) 361 (0.2)
Severe liver disease (%) 2431 (0.2) 318 (0.2) 3103 (0.2) 1030 (0.2) 453 (0.3)
Acute renal failure (%) 1026 (0.1) 75 (0.1) 644 (0.1) 239 (0.1) 60 (0.1)
Chronical renal failure (%) 1014 (0.1) 79 (0.1) 715 (0.1) 220 (0.1) 59 (0.1)
Other renal disease (%) 1446 (0.1) 151 (0.1) 1397 (0.1) 542 (0.1) 152 (0.1)
Cancer (%) 24,504 (2.0) 1011 (0.6) 15,701 (1.2) 6374 (1.2) 1689 (1.1)
COPD (%) 24,422 (2.0) 475 (0.3) 10,137 (0.8) 2440 (0.4) 493 (0.3)
Psoriasis (%) 5400 (0.4) 311 (0.2) 3816 (0.3) 1368 (0.3) 317 (0.2)
Atopic dermatitis (%) 754 (0.1) 327 (0.2) 1278 (0.1) 858 (0.2) 247 (0.2)
Rheumatic disease (%) 44,246 (3.6) 1561 (1.0) 30,506 (2.4) 10,474 (1.9) 2326 (1.5)
HIV (%) 485 (0.04) 103 (0.1) 370 (0.03) 146 (0.03) 45 (0.03)
Surgical procedurea (%) 6123 (0.5) 2363 (1.5) 11,576 (0.9) 6842 (1.2) 1448 (0.9)
Prosthetic deviceb (%)
• Cardiac 74 (0.01) 12 (0.01) 97 (0.01) 49 (0.01) 10 (0.01)
• Other 4755 (0.4) 1515 (0.9) 7742 (0.01) 3207 (0.6) 835 (0.5)
Chronic dialysis treatmentc (%) 33 (0.002) 7 (0.004) 18 (0.001) 10 (0.002) -
Socioeconomic status is defined as highest educational level prior to study inclusion
COPD, chronic obstructive pulmonary disease; HIV, human immune deficiency virus
aAny surgical procedure within 6 months prior to study entry. bCardiac devices: Pacemaker, prosthetic heart valves (mechanic/biological), cardiovascular stents.
Other devices: Hip and knee prosthesis, bone fracture treated with metal implants cDialysis treatment (irrespective of indication) within 6 months prior to
study entry
Fig. 2 Incidence rate ratios of Staphylococcus aureus bacteremia according to socioeconomic status. Incidence rate ratios (IRR) of SAB according
to SES adjusted for age, sex and calendar year (highest SES as reference)
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groups, i.e. 30–50 years (younger individuals), >50–
70 years (older individuals) and >70 years (retired indi-
viduals) (Fig. 3).
In absolute terms, risks of SAB were lowest among
young individuals aged 30–50 years (overall IR = 1.1/
100,000 person-years) and increased with advancing
age (overall IR = 3.5/100,000 person-years for 50–
70 years-olds, and overall IR = 7.7/100,000 person-
years for individuals >70 years). However, the highest
relative risks of SAB were observed in the youngest age
group with lowest educational level (basic school), and
the relative risks decreased with advancing age (Fig. 3).
Changing the age groups did not influence the pattern
of the results. An additional figure displays these results
[see Additional file 1].
In all models stratified by age, having a short/medium
length higher education was not associated with increased
risk of SAB compared with individuals with a Master’s
Degree/Ph.D.
Adjusting for comorbidities, prosthetic devices and
surgical procedures attenuated the inverse association
between decreasing SES and increasing risk of SAB, but
the pattern persisted (Fig. 4).
Risk of subsequent endocarditis
In patients with primary SAB (n = 13,181), 776 (5.9%)
individuals were diagnosed with endocarditis within 3
months (IR of 13.1/100,000 person-years). Endocarditis
was detected within the first week after hospitalization
with SAB for more than 73% of the cases (n = 569).
Nonetheless, SES was not associated with risk of subse-
quent endocarditis in patients diagnosed with SAB in a
model adjusted for age, sex and calendar year (e.g. IRR
of 1.20 [95% CI 0.79–1.81]) (Fig. 5). Additionally, the as-
sociation between SES and endocarditis in individuals
with SAB did not differ by age or sex, i.e. no interactions
were observed between SES, and age or sex. Lastly, the
lack of an association persisted in an analysis exploring
the risk of endocarditis in SAB patients prior to and
after 2007. An additional figure shows this in more detail
[see Additional file 2].
Other analyses
We further explored whether the cumulative follow-up
time individuals were exposed to selected comorbidities
prone to increase the risk of SAB and endocarditis
(diabetes, cancer, dialysis, surgical procedures, valvular
heart disease, pacemaker implantations and prosthetic
heart valve replacement) differed across SES levels, and
observed that individuals with basic school as highest
attained education were more exposed to these comor-
bidities. An additional table shows these results [see
Additional file 3].
Moreover, our finding of an inverse relation between
SES and risk of SAB was unaltered when SES was
defined by income in the year prior to study inclusion,
but the relative risk estimates were higher as illustrated
by an additional figure [see Additional file 4]. Lastly, the
lack of an association between SES and subsequent
endocarditis in patients with SAB did not appear to be
explained by a higher mortality rate among individuals
with low SES (Fig. 6).
Discussion
In this nationwide cohort study of a population where
everyone has free access to the healthcare system and has
the right to treatment without a charge, we observed that
declining level of SES was associated with an increasing
risk of microbiologically verified SAB. Specifically, the as-
sociated risk of SAB in individuals with basic school as
highest attained educational level was more than three-
fold increased compared with individuals with long higher
Fig. 3 Incidence rate ratios of Staphylococcus aureus bacteremia according to socioeconomic status and stratified by age groups. Incidence rate
ratios (IRR) of SAB according to SES stratified by age and adjusted for sex and calendar year (highest SES as reference)
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education. Additionally, the increased relative risks of
SAB were most pronounced in the youngest age
group and decreased with advancing age. Lastly, the
level of SES did not appear to be associated with risk
of subsequent endocarditis among patients diagnosed
with SAB.
It has been demonstrated that SES may influence the
subsequent risk of community-acquired bacteremia, and
mortality after hospitalization with bacteremia, primarily
due to a larger burden of drug-abuse and chronic dis-
eases in individuals with low SES [15, 16]. In our cohort,
individuals with low SES were more exposed to medical
conditions, surgical procedures, dialysis treatment and
implantations of both pacemakers and prosthetic heart
valves. However, although the Danish registries do not
hold information on all relevant risk factors the inequal-
ity in exposure to relevant risk factors only explained
part of the inverse association between decreasing SES
and increasing risk of SAB.
SAB is a rare condition in young adults [8], but our find-
ings suggest that the majority of individuals, who acquire
the disease in a fairly young age, are individuals with the
lowest SES. Noteworthy, it appeared that the impact of
SES decreased with advancing age, which may reflect that
with advancing age, age-related comorbidities become
more important for SAB risk than educational level.
Conversely, the definition of SES is more challenging
in the eldest, as well as in the youngest part of the popu-
lation with no definition of SES being perfect. Since the
study population was fairly young at study inclusion, we
found that educational level reflected SES better than
annual income and have therefore chosen this param-
eter. Moreover, defining SES as annual income the year
prior to study inclusion did not change the pattern of
the results.
As the association between SES and risk of SAB varied
by age we stratified the study population in to three age
groups. We included the population at the age of 30 years
Fig. 5 Incidence rate ratios of subsequent endocarditis in patients with Staphylococcus aureus bacteremia according to socioeconomic status.
Incidence rate ratios (IRR) of subsequent endocarditis in 13,181 patients with SAB according to SES adjusted for age, sex and calendar year
(highest SES as reference)
Fig. 4 Fully adjusted model of incidence rate ratios of Staphylococcus aureus bacteremia according to socioeconomic status and stratified by age
groups. The model is adjusted for sex, calendar year, diabetes, hypertension, acute myocardial infarction, hearth failure, valvular disease, cancer,
periphery vascular disease, cerebrovascular disease, mild/severe liver disease, acute/chronic renal failure, chronic obstructive pulmonary disease,
atopic dermatitis, psoriasis, rheumatic disorders, HIV, prosthetic devices, surgical procedures and dialysis treatment (highest SES as reference)
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and above to make sure that the majority had completed
their education. Additionally, we defined the eldest age-
group as >70 years to increase the likelihood that the
patients were in fact retired, since it is becoming in-
creasingly common for the elderly to remain on the
labor market after the age of 65 years, which is the offi-
cial age of retirement in Denmark. The study popula-
tion with an age younger than 70 years was stratified
into young (30–50 years) and older (>50–70 years) in-
dividuals at the labor market. In an additional analysis
using an age cutoff corresponding to the Danish case-
control study [16], the increased risk of SAB was still
driven by the increased risk in the youngest subjects,
which supports our age-categorization.
We chose to define SES as highest attained educa-
tional level at study entry since our study population
was relatively young, thus income would be a less ap-
propriate measure of SES. First, students are given sub-
sistence (a fairly low amount of money to live on)
during secondary and university education. Second,
newly educated individuals start on a lower income
right after end of their studies and third, retired indi-
viduals are given pensions, and thus all will be catego-
rized as having a low SES, if defined by income.
Furthermore, education is a fairly strong predictor of
an individual’s future employment and thereby income,
and education is unlikely to change after early adult-
hood [18]. Nonetheless, young individuals registered in
the lower categories of educational attainment might in
fact still be students in whom educational attainment
does not accurately reflect SES, but this is probably not
a substantial problem in our study, since we only in-
cluded individuals’ ≥30 years of age. Additionally, defin-
ing SES according to level of income did not change
the pattern of our findings.
Staphylococcus aureus is the leading cause of infective
endocarditis in several countries [28, 29], but we did
not find SES to be associated with subsequent risk of
endocarditis among patients diagnosed with SAB, and
the lack of an association did not appear to be caused
by a higher mortality rate in individuals with the lowest
SES. Importantly, we did not examine the overall asso-
ciation between SES and endocarditis, but rather if the
level of SES influenced whether SAB was followed by
endocarditis. The awareness of endocarditis increased
noticeably during our study period, and since 2007,
Danish guidelines have advocated doctors to perform
both trans-thoracic echocardiography as well as trans-
esophageal echocardiography in patients with SAB [27],
and the guidelines endorsed by the European Society of
Cardiology in 2009 [30] justify routine echocardiog-
raphy in these patients. Hence, our findings may sug-
gest that after 2007 patients with SAB are examined for
endocarditis in accordance with guideline recommenda-
tions irrespective of their SES. Unfortunately, we could
not investigate this further since information regarding
echocardiography was not digitalized before late 2006 and
echocardiographic data was not accessible through the
nationwide registries. However, we analyzed potential dif-
ferences in the association between SES and infective
Fig. 6 Cumulative incidence with death as competing risk. Cumulative incidence of endocarditis with death as competing risk in 13,181 SAB patients
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endocarditis in patients with SAB prior to and after 2007
and did not find any associations.
Strengths and limitations
The present study offers several major strengths: we
limited the risk of selection bias by including the entire
Danish population and achieving data from nationwide
registries; the completion of the Danish registers provides
a minimal loss to follow-up; the coverage and validity of
SES data is very high; and because SAB events were iden-
tified in the Staphylococcus aureus bacteremia Database,
only microbiologically confirmed events were reported.
There are however some limitations, which merit com-
ments. First of all, due to the register-based study design,
we were not able to obtain adequate information on risk
factors not systematically reported to the registries and
only reported for a minor part of the population, such as
information regarding intravenous drug abuse, dental pro-
cedures, smoking status or alcohol intake and comorbidi-
ties not in need of hospitalization or pharmacological
treatment (e.g. diet-treated diabetes). Importantly, our
main analysis of the association between SES and SAB ad-
justed for age, sex and calendar year and stratified by age
groups was not subject to any of these limitations.
Secondly, a major limitation of this study lies in the
registration of endocarditis, thus the ICD-10 codes for
endocarditis in the Danish National Patient Registry, does
not specify the microbiological etiology. Consequently,
not all endocarditis events may be caused by Staphylococ-
cus aureus. However, the majority of endocarditis events
in these patients were diagnosed within a week after
bacteremia diagnosis, and given the restrictive definition
of endocarditis within a time limit of 3 months following
SAB, this limitation is probably minor. We further ex-
cluded all patients with a diagnosis of endocarditis prior
to SAB. The exclusion process may have omitted individ-
uals whose SAB were in fact complicated by endocarditis,
but in whom endocarditis was registered electronically
prior to registration of SAB, resulting in possible under-
estimation of endocarditis events. Additionally, the num-
ber of endocarditis events following SAB could be
underestimated due to the 3 months time period, which
could explain why we observed a somewhat lower per-
centage of patients with subsequent endocarditis in our
population compared with other studies [11, 31, 32]. It
could also be explained by the fact that our study period
includes 10 years where doctors did not use echocardiog-
raphy routinely in patients hospitalized with SAB resulting
in fewer endocarditis events. Nonetheless, the association
appeared to be constant over time.
Identification of people at increased risk of SAB is an
important step in preventing the disease. Our findings
may contribute to increased awareness of the disease
and the populations at risk, minimize doctor’s delay,
and thereby improve the prognosis for these patients,
for whom correct and timely treatment is crucial.
Conclusion
We observed an inverse association between SES and
risk of SAB with the highest relative risks observed in
young adults (30–50 years old), which declined with
advancing age, but was demonstrated irrespective of age.
Additionally, the associations were only in part explained
by comorbidities and risk factors prone to increase the
risk of SAB. The level of SES did not influence the risk
of subsequent endocarditis in patients with SAB.
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